Among the 596 patients diagnosed with HER2+ ABC in 2008–2017, 179 (30%) patients were diagnosed with de novo HER2+ ABC (which was 32% (94/297) in 2013–2017 and 28% (85/301) in 2008–2012). This evidence concerns the gene ERBB2 and aneurysmal bone cyst.